Quadrivalent HPV vaccination after effective treatment of Anal Intraepithelial Neoplasia in HIV+ men
Phase of Trial: Phase IV
Latest Information Update: 09 Aug 2016
At a glance
- Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Anal intraepithelial neoplasia; Human papillomavirus infections
- Focus Therapeutic Use
- Acronyms VACCAIN-P
- 05 Aug 2016 Planned End Date changed from 1 Feb 2018 to 1 Sep 2018.
- 05 Aug 2016 Planned primary completion date changed from 1 Feb 2018 to 1 Sep 2018.
- 22 Dec 2015 Planned End Date changed from 1 Dec 2017 to 1 Feb 2018, as reported by ClinicalTrials.gov.